After Pfizer CEO Albert Bourla referred to the results as a "game-changer" in the global efforts to end the pandemic, the company's stock rose by nearly 11%. That marked the largest single-day price move in Pfizer's stock since 2009, according to the SEC."Insider trading is not a quick buck. It’s not easy money. It’s not a sure thing. It’s cheating. It’s a bad bet. It’s a ticket to prison," U.S. Attorney Damian Williams said in a statement Thursday.
Pfizer told FOX Business that the company is cooperating with the government's investigation into the matter. "The charges in this case relate to the personal conduct of a former Pfizer employee in violation of the company’s policies," a Pfizer spokesperson told FOX Business. At the time of the trade, Dagar was a senior statistical program lead for the Paxlovid drug trial, which began in July 2021, according to the